Skip to main

Top Losers

Last updated Jan 6, 2026 at 8:31 PM

Discover today’s top-losing stocks with real-time data to help investors and traders stay informed on the latest market shifts. This data includes the 50 US-listed stocks with the steepest losses, with key financial metrics like daily change, market cap, trading volume, and daily highs and lows.

Invest in stocks and more on Public

Public is an all-in-one investing platform where you can build a multi-asset portfolio that includes everything from stocks and options to bonds, crypto, and a High-Yield Cash Account.

Sign up now
NamePriceChangeMarket CapVolumeAnalyst RatingHigh TodayLow Today
TIL
Instil Bio
$6.65-45.91%76.44M2.38M$7$5.67
Trade
BVC
BitVentures Limited
$11.45-22.41%1.24B53.1K$13$11
BGL
Blue Gold Ltd
$2.12-21.19%83.73M488.33K$2.74$1.96
SLS
SELLAS Life Sciences Group
$4.07-18.67%619.63M25.38M$5.05$3.62
BNR
Burning Rock Biotech
$20.17-17.61%221.16M77.71K$24.92$20
THH
Tryhard Holdings Ltd
$18.45-16.44%1.02B117.82K$23.15$17.81
TGEN
Tecogen Inc
$4.64-16.34%159.39M3.23M$5.61$4.23
GANX
Gain Therapeutics
$2.53-14.98%114.24M2.99M$3.13$2.30
HKIT
Hitek Global Inc
$1.75-14.44%60.07M444.79K$2.09$1.40
ZKH
ZKH Group Ltd
$3.15-14.40%480.7M795.85K$3.79$3.15
PTNM
Pitanium Limited
$10.39-14.27%236.38M1.5M$12.09$9.80
GYRE
Gyre Therapeutics Inc
$6.85-13.57%719.86M139.8K$8.07$6.83
ATRA
Atara Biotherapeutics
$14.60-13.41%121.57M196.82K$17.65$14.27
ANGO
AngioDynamics
$11.49-13.19%545.08M2.69M$13.23$10.90
MH
McGraw Hill Inc
$14.50-12.99%3.19B898.64K$16.09$14.48
EQ
Equillium Inc
$1.38-12.42%95.61M545.66K$1.59$1.35
DGNX
Diginex Ltd
$4.00-12.20%918.88M1.23M$4.54$3.85
NBP
NovaBridge Biosciences
$3.87-11.44%503.83M2.77M$5.17$3.81
GALT
Galectin Therapeutics
$3.44-11.34%250.18M734.31K$3.95$3.34
UXIN
Uxin Ltd - ADR
$3.60-10.79%745.84M720.09K$4.18$3.52
ZBIO
Zenas Biopharma Inc
$14.85-10.60%1.86B2.64M$16.15$13.75
JCAP
Jefferson Capital Inc
$20.65-10.30%1.35B485.46K$21.44$20.25
SNT
Senstar Technologies Corp
$4.07-10.27%106.37M390.17K$4.63$4.04
LVWR
LiveWire Group Inc
$3.83-10.09%868.99M109.95K$4.25$3.65
ANRO
Alto Neuroscience Inc
$14.91-9.80%513.53M336.07K$16.40$14.29
OKYO
OKYO Pharma Ltd
$2.17-9.63%90.27M147.26K$2.47$2.10
ENTX
Entera Bio Ltd
$1.60-9.61%81.17M1.33M$1.81$1.59
AMBR
Amber International Holding Lt
$2.21-9.43%210.91M151.8K$2.47$2.21
CANF
Can-Fite BioPharma Ltd.
$3.89-9.37%112.34M165.85K$4.15$3.65
OMER
Omeros
$13.96-9.35%1.1B3.67M$15.13$13.57
SND
Smart Sand
$3.75-9.33%175.92M426.51K$4.26$3.72
FLD
Fold Holdings Inc
$2.48-8.82%131.4M160.33K$2.75$2.43
YDES
YD Bio Ltd
$11.59-8.64%846.26M310.54K$13.11$11.01
TE
T1 Energy Inc
$7.50-8.60%1.92B21.14M$8.14$7.09
STAA
STAAR Surgical
$21.93-8.40%1.18B5.95M$22.21$19.82
AGIG
Abundia Global Impact Group In
$2.10-8.30%79.31M231.18K$2.28$2.02
CSIQ
Canadian Solar
$23.13-8.14%1.69B4.59M$25$22.44
HIT
Health In Tech Inc
$1.55-8.12%96.18M238.11K$1.68$1.53
CCCX
Churchill Capital Corp X
$17.10-8.11%968.66M2.59M$19$16.95
GHRS
GH Research PLC
$14.21-8.09%958.98M672.03K$16.19$13.51
SOFI
SoFi Technologies
$26.94-8.00%34.62B100.72M$29.29$26.03
DOMH
Dominari Holdings Inc
$4.40-7.95%76.54M269.15K$4.76$4.37
FULC
Fulcrum Therapeutics Inc
$9.99-7.84%715.12M420.21K$10.76$9.81
ARDX
Ardelyx
$5.62-7.72%1.48B3.23M$6.12$5.62
CV
CapsoVision Inc
$7.84-7.66%397.7M1.03M$8.90$7.60
CRMD
CorMedix
$11.27-7.52%960.44M2.89M$12.29$11.19
LZMH
LZ Technology Holdings Ltd
$1.30-7.50%212.9M156.15K$1.49$1.28
VRCA
Verrica Pharmaceuticals Inc
$8.21-7.50%78.77M164.58K$8.93$7.90
GOSS
Gossamer Bio Inc
$2.54-7.48%634.19M4.14M$2.76$2.52
SION
Sionna Therapeutics Inc
$37.80-7.48%1.75B155.73K$41.65$37.76

*Analyst Ratings available to Premium Members only.

Market data by Xignite. In order to offer the best user experience, certain criteria were applied - Stocks with a market capitalization of less than 50 million, All OTC (over-the-counter) stocks, penny stocks (trading below $1 value), as well as stocks with an average daily volume of less than 10,000 over the past three months or less than 100,000 intraday volume were excluded from the dataset.

Please note that while we strive to provide accurate and up-to-date information, stock prices and other data may fluctuate and should be verified independently. We encourage users to conduct thorough research before making any investment decisions based on the information provided.